Remibrutinib, a novel BTK inhibitor, demonstrates promising efficacy and safety in chronic spontaneous urticaria
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Remibrutinib, a novel BTK inhibitor, demonstrates promising efficacy and safety in chronic spontaneous urticaria
Authors
Keywords
-
Journal
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-09-10
DOI
10.1016/j.jaci.2022.08.027
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bruton's tyrosine kinase inhibition—an emerging therapeutic strategy in immune‐mediated dermatological conditions
- (2022) Pedro Mendes‐Bastos et al. ALLERGY
- Targeting Bruton tyrosine kinase using non-covalent inhibitors in B cell malignancies
- (2021) Danling Gu et al. Journal of Hematology & Oncology
- Remibrutinib (LOU064): A selective potent oral BTK inhibitor with promising clinical safety and pharmacodynamics in a randomized phase I trial
- (2021) Martin Kaul et al. CTS-Clinical and Translational Science
- The International EAACI/GA²LEN/EuroGuiDerm/APAAACI Guideline for the Definition, Classification, Diagnosis and Management of Urticaria
- (2021) T. Zuberbier et al. ALLERGY
- Association of Chronic Spontaneous Urticaria With Anxiety and Depression in Adolescents: A Mediation Analysis
- (2021) Yuzhou Huang et al. Frontiers in Psychiatry
- Fenebrutinib in H1 antihistamine-refractory chronic spontaneous urticaria: a randomized phase 2 trial
- (2021) Martin Metz et al. NATURE MEDICINE
- Co‐occurrence of IgE and IgG autoantibodies in patients with chronic spontaneous urticaria
- (2020) R. Asero et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Discovery of LOU064 (Remibrutinib), a Potent and Highly Selective Covalent Inhibitor of Bruton’s Tyrosine Kinase
- (2020) Daniela Angst et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Fast and Clean BTK Inhibitor
- (2020) Ronen Gabizon et al. JOURNAL OF MEDICINAL CHEMISTRY
- The global burden of chronic urticaria for the patient and society
- (2020) M. Gonçalo et al. BRITISH JOURNAL OF DERMATOLOGY
- Chronic urticaria treatment patterns and changes in quality of life: AWARE study 2-year results
- (2020) Marcus Maurer et al. World Allergy Organization Journal
- Eosinopenia, in Chronic Spontaneous Urticaria, Is Associated with High Disease Activity, Autoimmunity, and Poor Response to Treatment
- (2019) Pavel Kolkhir et al. Journal of Allergy and Clinical Immunology-In Practice
- Ligelizumab for Chronic Spontaneous Urticaria
- (2019) Marcus Maurer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sexual Functioning Is Frequently and Markedly Impaired in Female Patients with Chronic Spontaneous Urticaria
- (2019) Ragıp Ertaş et al. Journal of Allergy and Clinical Immunology-In Practice
- The development of Bruton's tyrosine kinase (BTK) inhibitors from 2012 to 2017: A mini-review
- (2018) Chengyuan Liang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Potential applications of Bruton’s tyrosine kinase inhibitors for the prevention of allergic reactions
- (2017) Melanie C. Dispenza et al. Expert Review of Clinical Immunology
- Autoimmune chronic spontaneous urticaria: What we know and what we do not know
- (2017) Pavel Kolkhir et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- ATTENTUS, a German online survey of patients with chronic urticaria highlighting the burden of disease, unmet needs and real-life clinical practice
- (2016) M. Maurer et al. BRITISH JOURNAL OF DERMATOLOGY
- Updosing nonsedating antihistamines in patients with chronic spontaneous urticaria: a systematic review and meta-analysis
- (2016) S. Guillén-Aguinaga et al. BRITISH JOURNAL OF DERMATOLOGY
- Investigational Bruton’s tyrosine kinase inhibitors for the treatment of rheumatoid arthritis
- (2016) Peter Norman EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The urticarias: pathophysiology and management
- (2013) C. Grattan CLINICAL MEDICINE
- Urticaria
- (2013) Brigid F. O’Donnell IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
- Model-based dose finding under model uncertainty using general parametric models
- (2013) José Pinheiro et al. STATISTICS IN MEDICINE
- Pharmacology of antihistamines
- (2013) MartinK Church et al. INDIAN JOURNAL OF DERMATOLOGY
- Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report1
- (2010) M. Maurer et al. ALLERGY
- Development of a daily diary for patients with chronic idiopathic urticaria
- (2010) Susan D. Mathias et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- The Src, Syk, and Tec family kinases: Distinct types of molecular switches
- (2010) J. Michael Bradshaw CELLULAR SIGNALLING
- The effects of dasatinib on IgE receptor-dependent activation and histamine release in human basophils
- (2008) M. Kneidinger et al. BLOOD
- Chronic urticaria: an internet survey of health behaviours, symptom patterns and treatment needs in European adult patients
- (2008) M. Maurer et al. BRITISH JOURNAL OF DERMATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started